GlassScriptPhysician profile
David Benjamin Leventer
NPI 1578659835
$843.37
in general payments reported to CMS, 2019-2025
19 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.43 · 2020: $126 · 2021: $33.73 · 2022: $157 · 2023: $54.98 · 2024: $179 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $336.33 | 2022-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Bausch & Lomb Americas INC. | $82.08 | 2022-2023 | Stellaris |
| Novartis Pharmaceuticals Corporation | $53.60 | 2019-2020 | |
| Amgen INC. | $51.41 | 2024-2025 | Tepezza |
| Allergan, INC. | $49.38 | 2020-2022 | |
| Lilly USA, LLC | $32.99 | 2025 | Ebglyss, Taltz |
| Oyster Point Pharma, INC. | $31.21 | 2022-2023 | Tyrvaya |
| New World Medical,INC. | $27.74 | 2020 | |
| Eyevance Pharmaceuticals LLC | $25.93 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $20.23 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Rayner Intraocular Lenses Limited | $16.83 | 2022 | |
| Abbvie INC. | $16.07 | 2022 | |
| Maculogix, INC. | $14.96 | 2020 | |
| Dompe US, INC. | $14.95 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $14.52 | 2019 | |
| Ocular Therapeutix, INC. | $14.41 | 2020 | |
| Horizon Therapeutics Plc | $12.58 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Leventer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.